dusquetide
·Code: SGX945
dusquetide: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| SOLIGENIX, INC. (SNGX) | Phase 2 |
Clinical Trials (1)
Pilot Study of SGX945 (Dusquetide) in the Treatment of Aphthous Ulcers in Behcet's Disease
Frequently asked questions
Who is developing dusquetide?
dusquetide is being developed by SOLIGENIX, INC..
How many clinical trials involve dusquetide?
BioSniper tracks 1 clinical trial involving dusquetide.
Get deeper analysis on dusquetide
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis